BTC-86

N/A

Report date: 2025/03/25 14:24:25
NME

Base Information

Drug NameBTC-86
Drug Alias NameBTC-86
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin/Histone-lysine N-methyltransferase 2A MLL inhibitorsMenin inhibitors
TargetsMenin
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeyang Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeyang Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A